×
Thursday, October 2, 2025

Author

NewsService

News Service

Matinas BioPharma Announces Infectious Diseases Society of America (IDSA) has Selected the EnACT Phase 2 Trial Abstract of MAT2203 as its Outstanding Abstract and IDSA Awardee For IDWeek 2022

Wed, Oct 19, 2022 08:15 ET

FTI Consulting’s Technology Segment Expands Corporate Legal Department Transformation Solutions

Wed, Oct 19, 2022 08:15 ET

Dynacor Reports Sales U$46.0 Million (C$60.1 Million) for the Third Quarter of 2022

Wed, Oct 19, 2022 08:15 ET

First Tellurium Reports on Recent Channel Sampling at Deer Horn

Wed, Oct 19, 2022 08:15 ET

Foxpoint Announces Joshua Krause as Chief Operating Officer to Drive Strategic Business Initiatives

Wed, Oct 19, 2022 08:15 ET

Arctic Monkeys Talk the Band’s Evolution, New Album in SPIN Magazine Cover Story

Wed, Oct 19, 2022 08:15 ET

Should Your Law Firm Invest in SEO, PPC or Both? | New Jersey Law Journal - Law.com

Wed, Oct 19, 2022 08:05 ET

Spelling & Grammar: Are They Google Ranking Factors? - Search Engine Journal

Wed, Oct 19, 2022 08:05 ET

Steve Madden Announces Third Quarter 2022 Earnings Release Date

Wed, Oct 19, 2022 07:20 ET

Advaxis and Ayala Pharmaceuticals Enter into Merger Agreement

Wed, Oct 19, 2022 07:20 ET

Cerevel Therapeutics to Report Third Quarter 2022 Financial Results and Pipeline Update on Tuesday, November 8, 2022

Wed, Oct 19, 2022 07:20 ET

Ayala Pharmaceuticals and Advaxis Enter into Merger Agreement

Wed, Oct 19, 2022 07:20 ET
© SubmitMyPR All Rights Reserved 2012 - 2025